Insider · CIK 0001591756

Martin G. Kelly

Reports to the SEC for 3 companies · ANAHEIM, CA

sec.gov

Transactions

Companies

Filings

CIK

0001591756

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-08-15	Radius Health, Inc.D Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−75K sh	$10.00	−$750K	0
2022-02-21	Radius Health, Inc.A Award	Director, CEO and President	AAward	+75K sh	—	—	75,000
2022-02-21	Radius Health, Inc.A Award	Director, CEO and President	AAward	+960K sh	—	—	960,000
2021-02-22	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+460K sh	—	—	460,000
2021-02-22	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+460K sh	—	—	460,000
2020-04-28	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+575K sh	—	—	575,000
2019-07-31	NVN Liquidation, Inc.Stock Appreciation RightA Award	Director, Chief Executive Officer	AAward	+1M sh	—	—	1,000,000
2019-05-29	NVN Liquidation, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,500 sh	$1.97	+$2,955	45,000
2019-05-28	NVN Liquidation, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,500 sh	$2.15	+$7,525	43,500
2019-05-17	NVN Liquidation, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	$1.43	+$28.6K	60,000
2019-05-17	NVN Liquidation, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+40K sh	$1.43	+$57.2K	40,000
2018-09-26	NVN Liquidation, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$2.73	+$27.3K	40,000
2018-08-21	NVN Liquidation, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+30K sh	$2.71	+$81.3K	30,000
2017-06-05	NVN Liquidation, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+34K sh	—	—	34,014
2016-09-20	NVN Liquidation, Inc.Stock OptionA Award	Director, Chief Executive Officer	AAward	+14.5K sh	—	—	14,484
2014-08-14	QUESTCOR PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−2,812 sh	—	—	0
2014-08-14	QUESTCOR PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,160 sh	—	—	0
2013-11-09	QUESTCOR PHARMACEUTICALS INCA Award	Director	AAward	+2,812 sh	—	—	2,812
2013-11-09	QUESTCOR PHARMACEUTICALS INCStock Option (right to purchase)A Award	Director	AAward	+6,187 sh	—	—	6,187

Recent filings

Accepted (ET)
Aug 154
Martin G. Kelly0000899243-22-028635
SEC(opens sec.gov)
Feb 254
Martin G. Kelly0001209191-22-013190
SEC(opens sec.gov)
Feb 234
Martin G. Kelly0001209191-22-012309
SEC(opens sec.gov)
Mar 244/A
Martin G. Kelly0001209191-21-022919
SEC(opens sec.gov)
Feb 234
Martin G. Kelly0001209191-21-013323
SEC(opens sec.gov)
Apr 294
Martin G. Kelly0001209191-20-026151
SEC(opens sec.gov)
Aug 24
Martin G. Kelly0001467154-19-000063
SEC(opens sec.gov)
May 304
Martin G. Kelly0001467154-19-000046
SEC(opens sec.gov)
May 294
Martin G. Kelly0001467154-19-000044
SEC(opens sec.gov)
May 214
Martin G. Kelly0001467154-19-000033
SEC(opens sec.gov)
Sep 274
Martin G. Kelly0001467154-18-000002
SEC(opens sec.gov)
Aug 234
Martin G. Kelly0001209191-18-048180
SEC(opens sec.gov)
Jun 74
Novan, Inc.0001209191-17-038408
SEC(opens sec.gov)
Sep 224
Novan, Inc.0000899243-16-029749
SEC(opens sec.gov)
Aug 184
QUESTCOR PHARMACEUTICALS INC0001209191-14-053195
SEC(opens sec.gov)
Nov 134
QUESTCOR PHARMACEUTICALS INC0001181431-13-058832
SEC(opens sec.gov)

Companies

Address

1300 NORTH KELLOGG DRIVE, SUITE D

ANAHEIM, CA, 92807